Client Feedback
Brian had an excellent grasp of trends in biomarker discovery and personalized medicine, and worked with EPI’s management team to refine our corporate strategy. As VP of Business Development, Brian negotiated several important licensing, partnering, and biomarker discovery deals for EPI. He did an excellent job of resolving issues and taking the deals to completion.
Casey Eitner, President and CEO, Expression Pathology Inc.
-
From the Lab2Mkt Blog
- Will ApoE Test become a Companion Diagnostic for Bexarotene?
- What’s My Early-Stage Life Science Company Worth?
- New Market Research Services
- The Right Way to Start a Company
- HIV Molecular Diagnostics in India
- What’s the Current In Vitro Diagnostics Market Growth Rate?
- Guerilla Market Research
- Sensitivity and Specificity Key Issues Both for Google Adwords® and Molecular Diagnostics
- Website Redux: Growingcos.com Reborn
View and download “Early-Stage Life Science Company Valuation” in pdf format.
We welcome your feedback: btaylor@growingcos.com